LongPODDAug 2026
Insulet Corporation
Insulet has a near-monopoly in insulin patch pumps through its Omnipod platform. Second-quarter revenue and earnings exceeded expectations, although management lowered 2026 US…
PODD
2 published ideas on Insulet Corporation across 1 fund — 2 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Insulet Corporation: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Insulet has a near-monopoly in insulin patch pumps through its Omnipod platform. Second-quarter revenue and earnings exceeded expectations, although management lowered 2026 US…
Insulet has a near-monopoly in insulin patch pumps through its Omnipod platform. Second-quarter revenue and earnings exceeded expectations, although management lowered 2026 US…